Effect and Mechanism of Modified Banxia Xiexintang on Depression During Perimenopause

Jia PAN; Qiang HU; Jun-jun YANG; Ben-yan SONG; Nan NING; Li HUANG; Jie LIU; Ya-ou LIU; Yan-li DENG; Ya YU; Li-min LI

doi:10.13422/j.cnki.syfjx.20192134

您当前的位置：

首页 >

文章列表页 >

Effect and Mechanism of Modified Banxia Xiexintang on Depression During Perimenopause

Classic Prescriptions | 更新时间：2021-02-09

- Effect and Mechanism of Modified Banxia Xiexintang on Depression During Perimenopause
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 3, Pages: 15-20(2020)
- 作者机构：
  
  1.四川省中医药科学院，成都　 610041
  2.攀枝花学院　附属医院，四川攀枝花　 617000
  3.四川省中西医结合医院，成都　 610024
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20192134
  CLC： R289.3; R71; R711; 271.11
- Received：27 June 2019，
  
  Published Online：30 July 2019，
  
  Published：05 February 2020
- 稿件说明：
移动端阅览
Jia PAN, Qiang HU, Jun-jun YANG, et al. Effect and Mechanism of Modified Banxia Xiexintang on Depression During Perimenopause[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(3): 15-20.
DOI：

Jia PAN, Qiang HU, Jun-jun YANG, et al. Effect and Mechanism of Modified Banxia Xiexintang on Depression During Perimenopause[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(3): 15-20. DOI： 10.13422/j.cnki.syfjx.20192134.

摘要

目的：

观察半夏泻心汤加减治疗围绝经期抑郁症的临床疗效及对5-羟色胺(5-HT)和促炎因子的影响。

方法：

将139例患者随机按数字表法分为对照组69例和观察组70例。对照组口服替勃龙片，2.5 mg/次，1次/d；口服盐酸帕罗西汀片，20 mg/次，1次/d。观察组西药治疗同对照组，并内服半夏泻心汤加减，1剂/d。两组疗程均为连续治疗8周。进行治疗前后汉密尔顿抑郁量表17项(HAMD-17)，Zung氏抑郁自评量表(SDS)，汉密尔顿焦虑量表(HAMA)，改良Kupperman(KI)，肝郁脾虚证和围绝经期综合征生活质量评定量表(MENQOL)评分；检测治疗前后5-HT，肿瘤坏死因子-

(TNF-

)，白细胞介素-1

(IL-1

)和脑源性神经营养因子(BDNF)，进行不良反应量表(TESS)评价。

结果：

治疗后观察组HAMD-17和SDS评分均低于对照组(

0.01)；观察组抑郁症疗效优于对照组(

＝2.074，

0.05)；观察组抑郁程度轻于对照组(

＝2.157，

0.05)；观察组患者的HAMA，KI和肝郁脾虚证评分均低于对照组(

0.01)；观察组围绝经期综合征严重程度轻于对照组(

＝2.046，

0.05)；观察组MENQOL量表血管舒缩症状和心理症状2个维度评分和总分均低于对照组(

0.05)；治疗后观察组5-HT高于对照组，BDNF高于对照组(

0.01)，TNF-

，IL-1

水平均低于对照组(

0.01)；观察组TESS评分低于对照组(

0.01)。

结论：

在常规西医治疗的基础上，加服半夏泻心汤加减能进一步改善抑郁、焦虑和围绝经期综合(PMS)症状，提高生活质量，并可抑制促炎因子，增强5-HT，BDNF表达，且无不良事件发生。

Abstract

Objective:

To observe the effect of modified Banxia Xiexintang on depression during perimenopause

in order to study itseffecton 5-hydroxytryptamine (5-HT) and proinflammatory factors.

Method:

One hundred and thirty-nine patients were randomly divided into control group (69 cases) and observation group (70 cases) by random number table.Patients in control group got tibolone tablets

2.5 mg/time

1 time/day

and paroxetine hydrochloride tablets

20 mg/time

1 time/day.In addition to the therapy in control group

patients in observation group were added with modified Banxia Xiexintang

1 dose/day.The course of treatment was 8 weeks.And before and after treatment

Hamilton depression scale for-17 items (HAMD-17)

Zung's self-rating depression scale (SDS)

hamilton anxiety scale (HAMA)

improvement Kupperman(KI)

liver depression and spleen deficiency syndrome

menopause-specific quality of life questionnaire (MENQOL) and treatment emergent symptom scale (TESS) were scored

and levels of 5-HT

rain-derived neurotrophic factor (BDNF)

interleukin-1

(IL-1

) and tumor necrosis factor-

(TNF-

) were detected.

Result:

After treatment

scores of HAMD-17 and SDS in observation group were lower than those in control group (

0.01). And the effect on trea depression in observation group was better than that in control group (

=2.074

0.05). The degree of depression in observation group was ligher than that in control group (

=2.157

0.05). And scores of HAMA

KI and liver depression and spleen deficiency syndrome were lower than those in control group (

0.01). The severity of perimenopausal syndrome was ligher than that in control group (

=2.046

0.05). And scores of vasomotor symptoms and psychological symptoms of MENQOL scale and the total scores were lower than those in control group (

0.05). Levels of 5-HT and BDNF were higher than those in control group (

0.01)

while levels of IL-1

TNF-

and TESS were lower than those in control group (

0.01).

Conclusion:

In addition to theroutine western medicine

modified Banxia Xiexintang can alleviate the severity of depression

release the symptoms of depression

anxiety and perimenopausal syudrome(PMS)

improve the quality of life

inhibit pro-inflammatory factors

and enhance the expressions of 5-HT and BDNF

with no adverse event.

关键词

Keywords

references

李瑞霞，马敏，肖喜荣，等 . 40～55岁社区妇女围绝经期症状和焦虑、抑郁症状评分及相关因素分析 [J]．复旦学报：医学版， 2017 ， 44 ( 1 )： 27 - 33 .

金勤，黄铖，花琪，等．更年期门诊妇女绝经综合征与抑郁症状相关性的初步研究 [J]．中华生殖与避孕杂志， 2018 ， 38 ( 6 )： 441 - 447 .

司夏樱，岳秀宁，王昕，等．舒肝解郁胶囊联合重复经颅磁刺激治疗对围绝经期抑郁神经内分泌功能的影响 [J]．中国实验方剂学杂志， 2019 ， 25 ( 1 )： 163 - 168 .

王旭东，乔明琦，张樟进，等．中医药治疗抑郁症的研究进展 [J]．南京中医药大学学报， 2016 ， 32 ( 1 )： 93 - 96 .

李志强，常红娟．半夏泻心汤抗抑郁作用实验研究 [J]．中国实验方剂学杂志， 2013 ， 19 ( 4 )： 280 - 282 .

孙辉，李锦绣．半夏泻心汤合并帕罗西汀治疗女性躯体形式障碍对照研究 [J]．精神医学杂志， 2014 ， 27 ( 2 )： 128 - 130 .

潘嘉，宁楠，黄利，等．半夏泻心汤对肝郁模型大鼠cAMP，PKA水平以及单胺类神经递质的影响 [J]．中药与临床， 2018 ， 9 ( 4 )： 32 - 35 .

宁楠，黄利，刘洁，等．半夏泻心汤对肝郁模型大鼠行为活动的影响 [J]．中药药理与临床， 2017 ， 33 ( 3 )： 11 - 13 .

张吉仲，李利民，黄利，等．半夏泻心汤及其拆方对脾虚大鼠下丘脑中多巴胺、去甲肾上腺素和5-羟色胺的影响 [J]．华西药学杂志， 2014 ， 29 ( 3 )： 286 - 288 .

中华医学会．临床诊疗指南-妇产科学分册 [M]．北京：人民卫生出版社， 2009 ： 31 - 33 .

中华医学会精神科分会．中国精神疾病分类方案与诊断标准(CCMD-3) [M]. 3版．济南：山东科学技术出版社， 2001 ： 103 - 104 .

中华中医药学会．中医内科常见病诊疗指南-西医疾病部分 [M]．北京：中国中医药出版社， 2008 ： 293 - 299 .

杨洪艳，成芳平，王小云，等．绝经期生存质量量表中文版本的临床应用与评价 [J]．中华流行病学杂志， 2005 ， 26 ( 1 )： 47 - 50 .

王贵贤，常麦会，李庆丽，等．舒肝颗粒治疗围绝经期肝郁气滞型抑郁症的疗效观察 [J]．中国实验方剂学杂志， 2019 ， 25 ( 6 )： 114 - 119 .

张倩倩，黄文玲，魏爱平．围绝经期综合征合并抑郁倾向患者中医证候学特点调查 [J]．中医药导报， 2018 ， 24 ( 22 )： 74 - 76，83 .

孙占玲，金亚蓓，项洪艳，等．穴位埋线治疗肾虚肝郁证围绝经期轻度抑郁患者临床观察 [J]．中国针灸， 2015 ， 35 ( 5 )： 443 - 446 .

罗晓杰，陈锦黎．陈锦黎教授治疗围绝经期综合征经验 [J]．湖南中医杂志， 2013 ， 29 ( 6 )： 26 - 27 .

李玉凤，张碧严，赖芸，等．半夏泻心汤对氟尿嘧啶致腹泻小鼠模型肠道免疫功能的影响 [J]．中国实验方剂学杂志， 2014 ， 20 ( 23 )： 180 - 184 .

颜美玲，杨柳，侯阿娇，等．柴胡化学成分及药理作用研究进展 [J]．中医药信息， 2018 ， 35 ( 5 )： 103 - 109 .

杨丽梅，岳广欣．白芍总苷及其神经精神药理作用研究概况 [J]．河北中医， 2017 ， 39 ( 4 )： 614 - 618 .

周蕾，王梦楠，朱霄，等．刺五加对中枢神经系统的活性成分、药理作用及临床应用 [J]．湖南中医药大学学报， 2018 ， 38 ( 8 )： 961 - 964 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pharmacokinetic Differences of Seven Components in Different Phases of Banxia Xiexintang in Rats

Correlation Between Quality of Life and Traditional Chinese Medicine Syndromes in Patients with Myasthenia Gravis

Pathogenesis of Spleen and Stomach Diseases and Therapeutic Effect of Banxia Xiexintang Based on Theory of "Mutual Interference of Clear and Turbid Qi" in Huangdi Neijing

Mechanism and Research Progress of Banxia Xiexintang in Treating Ulcerative Colitis Based on Shanghanlun

Mechanism on Banxia Xiexintang Inducing Ferroptosis in Gastric Cancer Cells Based on Nrf2/GPX4 Signaling Pathway

Related Author

HE Chao

LIU Siyi

WANG Mingyun

WANG Qi

ZHOU Jingwen

ZHANG Tong

PU Yiqiong

ZHANG Yibin

Related Institution

School of Pharmacy，Shanghai University of Traditional Chinese Medicine

Changchun University of Chinese Medicine

The Third Affiliated Clinical Hospital of Changchun University of Chinese Medicine

The Affiliated Hospital of Changchun University of Chinese Medicine

Wangjing Hospital， China Academy of Chinese Medical Sciences

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰